AlphaFold predicted structure
CRLS1 · Q9UJA2

Mean pLDDT
69.0/ 100
Low
301 residues
Confidence breakdown
- Very high(≥ 90)35%
- Confident(70–90)21%
- Low(50–70)12%
- Very low(< 50)33%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
cardiolipin synthase 1
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Likely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalMitochondrial disorders
BIALLELIC, autosomal or pseudoautosomalMonogenic hearing loss
BIALLELIC, autosomal or pseudoautosomalPossible mitochondrial disorder - nuclear genes
BIALLELIC, autosomal or pseudoautosomalPaediatric or syndromic cardiomyopathy
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalcombined oxidative phosphorylation deficiency 57
stroke disorder
alcohol drinking
mitochondrial disease
inborn mitochondrial metabolism disorder
colorectal cancer
colonic neoplasm
hypertensive disorder
osteoarthritis, hip
colon carcinoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Cardiolipin synthase (CMP-forming)
Catalyzes the synthesis of cardiolipin (CL) (diphosphatidylglycerol) by specifically transferring a phosphatidyl group from CDP-diacylglycerol to phosphatidylglycerol (PG) (PubMed:16547353, PubMed:16678169, PubMed:16716149, PubMed:35147173). CL is a key phospholipid in mitochondrial membranes and plays important roles in maintaining the functional integrity and dynamics of mitochondria under both optimal and stress conditions (PubMed:35147173)
CRLS1 · Q9UJA2

Mean pLDDT
69.0/ 100
Low
301 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0